You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: RE46621


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent RE46621 protect, and when does it expire?

Patent RE46621 protects COPIKTRA and is included in one NDA.

This patent has forty patent family members in twenty-three countries.

Summary for Patent: RE46621
Title:Processes for preparing isoquinolinones and solid forms of isoquinolinones
Abstract: Polymorphs of chemical compounds that modulate kinase activity, including PI3 kinase activity, and compounds, pharmaceutical compositions, and methods of treatment of diseases and conditions associated with kinase activity, including P13 kinase activity, are described herein. Also provided herein are processes for preparing compounds, polymorphs thereof, and pharmaceutical compositions thereof.
Inventor(s): Ren; Pingda (San Diego, CA), Martin; Michael (San Marcos, CA), Isbester; Paul (Castleton, NY), Lane; Benjamin S. (Lynnfield, MA), Kropp; Jason (Westford, MA)
Assignee: Infinity Pharmaceuticals, Inc. (Cambridge, MA)
Application Number:15/051,529
Patent Claim Types:
see list of patent claims
Composition; Compound;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent RE46621: A Comprehensive Analysis

Introduction

Patents are crucial for protecting intellectual property and encouraging innovation. The United States Patent RE46621, a reissue patent, presents a complex landscape that requires a detailed analysis to understand its scope, claims, and implications. This article will delve into the key aspects of this patent, including its claims, the patent landscape, and the tools and methodologies used to analyze and navigate this landscape.

What is a Reissue Patent?

A reissue patent is a new patent that is issued to replace an original patent, often to correct errors or to broaden or narrow the scope of the original claims. Understanding the nature of a reissue patent is essential for grasping the context and implications of Patent RE46621[4].

Claims Analysis

Claim Structure

The claims of a patent are its most critical components, as they define the scope of the invention and what is protected. In the case of Patent RE46621, each claim must be carefully examined to understand what is being claimed and how it differs from the original patent.

Claim Types

Patents typically include various types of claims, such as independent claims, dependent claims, and method claims. Independent claims stand alone and define the invention broadly, while dependent claims refer back to and further limit the independent claims. Method claims describe the steps involved in the invention.

Claim Eligibility

The 2024 USPTO guidance update on AI patent eligibility is particularly relevant here. It emphasizes the importance of integrating judicial exceptions into practical applications to ensure patent eligibility. For Patent RE46621, it is crucial to assess whether the claims integrate abstract ideas into practical applications, providing meaningful limits and tangible benefits[1].

Patent Landscape

Patent Analytics

To understand the patent landscape surrounding RE46621, patent analytics tools are invaluable. These tools help identify which patents and claims are actively protecting the intellectual property and where gaps or opportunities exist. A Claim Coverage Matrix, for example, categorizes patents by claims and scope concepts, facilitating a comprehensive analysis of the patent landscape[3].

Claim Charts and Scope Concepts

Claim charts generated by tools like ClaimScape® can help visualize the coverage of the patent claims. These charts are essential for determining whether a particular scope concept is applicable to a target product or method, highlighting areas where claim coverage may be lacking and identifying future design opportunities[3].

Tools for Patent Search and Analysis

USPTO Resources

The USPTO provides several resources for searching and analyzing patents. The Patent Public Search tool, for instance, offers enhanced access to prior art and improves the overall patent searching process. The Global Dossier service allows users to view the file histories of related applications from participating IP Offices, which is useful for understanding the broader patent family[4].

International Patent Databases

Searching international patent databases, such as those provided by the European Patent Office (EPO), Japan Patent Office (JPO), and World Intellectual Property Organization (WIPO), is crucial for ensuring that the invention is novel and non-obvious on a global scale. These databases offer access to machine translations and full-text searches of published international patent applications[4].

Practical Applications and Technological Improvements

Real-World Applications

The 2024 USPTO guidance highlights the importance of demonstrating real-world applications of the claimed method or system. For Patent RE46621, it is essential to show how the abstract ideas are applied in a way that provides concrete benefits or solves specific problems in the relevant field. This could involve specifying the use of the invention in a practical, real-time application that enhances technology or provides a tangible outcome[1].

Technological Improvements

Claims that merely involve routine data processing without any inventive concept or practical application are unlikely to be patent-eligible. In contrast, claims that specify the use of the invention in a way that improves related technical fields are more likely to be eligible. For example, if the claims in RE46621 specify the use of the invention to enhance the accuracy of voice commands in hands-free environments, this would demonstrate a clear technological improvement[1].

Case Law and Judicial Precedents

Incorporation of Recent Case Law

The 2024 USPTO guidance update incorporates recent case law to provide clearer guidelines on patent eligibility. For Patent RE46621, understanding how recent judicial decisions impact the eligibility of similar claims is vital. This involves analyzing whether the claims integrate judicial exceptions into practical applications, as seen in examples provided by the USPTO guidance[1].

Stakeholder Engagement and Public Comments

Public Input and Consultative Groups

The process of analyzing and refining patent claims often involves stakeholder engagement. For instance, the Administrative Conference of the United States (ACUS) study on a small claims patent court included public comments and input from a consultative group of academic experts and legal practitioners. Such engagement ensures that all stakeholders have an opportunity to provide input and helps in creating a more robust and fair patent system[2].

Key Takeaways

  • Claim Eligibility: Ensure that claims integrate judicial exceptions into practical applications to meet patent eligibility criteria.
  • Patent Analytics: Use tools like Claim Coverage Matrix and Claim Charts to analyze the patent landscape and identify gaps or opportunities.
  • Real-World Applications: Demonstrate how the claimed method or system provides concrete benefits or solves specific problems in the relevant field.
  • Technological Improvements: Specify the use of the invention in a way that improves related technical fields.
  • Case Law: Incorporate recent judicial decisions to ensure compliance with current patent eligibility guidelines.

FAQs

Q: What is the significance of the 2024 USPTO guidance update on AI patent eligibility?

A: The update clarifies the process for determining the patent eligibility of AI-related inventions, emphasizing the integration of judicial exceptions into practical applications and ensuring that AI-assisted inventions are evaluated on equal footing with other technologies.

Q: How can patent analytics tools help in understanding the patent landscape?

A: Patent analytics tools, such as Claim Coverage Matrix and Claim Charts, help categorize patents by claims and scope concepts, facilitating a comprehensive analysis of the patent landscape and identifying gaps or opportunities.

Q: What resources are available for searching international patent databases?

A: Resources include the European Patent Office (EPO), Japan Patent Office (JPO), World Intellectual Property Organization (WIPO), and other international intellectual property offices, which provide access to machine translations and full-text searches of published international patent applications.

Q: Why is it important to demonstrate real-world applications of the claimed method or system?

A: Demonstrating real-world applications is crucial for showing that the abstract ideas are applied in a way that provides concrete benefits or solves specific problems in the relevant field, thereby meeting the criteria for patent eligibility.

Q: How does recent case law impact the eligibility of patent claims?

A: Recent case law, as incorporated into the 2024 USPTO guidance update, provides clearer guidelines on patent eligibility by emphasizing the integration of judicial exceptions into practical applications and specifying the use of the invention in a way that improves related technical fields.

Sources

  1. Understanding the 2024 USPTO Guidance Update on AI Patent Eligibility - Mintz
  2. U.S. Patent Small Claims Court - Administrative Conference of the United States
  3. Patent Analytics - Schwegman, Lundberg & Woessner, P.A.
  4. Search for Patents - United States Patent and Trademark Office
  5. Patents and Patentability - University of Minnesota Libraries

More… ↓

⤷  Subscribe


Drugs Protected by US Patent RE46621

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Secura COPIKTRA duvelisib CAPSULE;ORAL 211155-001 Sep 24, 2018 RX Yes No RE46621 ⤷  Subscribe Y Y ⤷  Subscribe
Secura COPIKTRA duvelisib CAPSULE;ORAL 211155-002 Sep 24, 2018 RX Yes No RE46621 ⤷  Subscribe Y Y ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent RE46621

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 084824 ⤷  Subscribe
Argentina 117467 ⤷  Subscribe
Australia 2012205669 ⤷  Subscribe
Australia 2015258280 ⤷  Subscribe
Brazil 112013017670 ⤷  Subscribe
Canada 2824197 ⤷  Subscribe
Chile 2013002007 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.